Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GOLGB1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GOLGB1 mRNA | affects expression | 16483693
|
D003010 |
Clorgyline |
Clorgyline results in increased expression of GOLGB1 mRNA | increases expression | 19691856
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GOLGB1 mRNA | increases expression | 20106945
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of GOLGB1 mRNA | affects cotreatment|increases expression | 17183730
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GOLGB1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of GOLGB1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.88 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.21 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.88 | 16434500 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.68 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.79 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 16609825 18316065 18775368 18558336 17157402 20603192 18177632 17507914 19460635 15238991 18940202 18985861 19232924 18396377 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.20 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.43 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.57 | 8888407 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.78 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.19 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.19 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.79 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.44 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.44 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.38 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.16 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.16 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.35 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.76 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.51 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.36 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.06 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.84 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.66 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.46 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.77 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.77 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.77 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.33 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.46 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.50 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.62 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.69 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.82 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.35 | 16221962 18467677 19772884 19176532 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.18 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.98 | 16612254 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.80 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.88 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.48 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.06 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.06 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.70 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.70 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.70 | 6135515 2876784 2876786 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.70 | 17228818 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.23 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.38 | 18803445 18765137 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.30 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.24 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.26 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.06 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.88 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.53 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.30 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.70 | 16049721 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.47 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.23 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Clorgyline |
4.24 | 19691856 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.98 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.48 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.55 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.55 | 3137016 15475178 14763951 11738929 11044598 16876388 1511512 17978042 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.99 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.98 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.68 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.92 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.38 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.00 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.71 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.43 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.88 | 17120751 |